Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kimberly Clark Corp (KMB) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

Kimberly Clark CorpTrade
Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Kimberly Clark Corp vs Regeneron Pharmaceuticals Inc — how do they compare? Kimberly Clark Corp trades at $108.57 (market cap $36.11B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 2.3× Kimberly Clark Corp's market cap, and Kimberly Clark Corp pays the higher dividend (4.72%). Which is the better fit depends on your goals.

KMBREGN
Market Cap
$36.11B$82.06B
Sector
Consumer StaplesHealth
52-Week High
$134.81$812.27
52-Week Low
$93.05$555.51
Enterprise Value
$41.67B$76.77B
Dividend Yield
4.72%0.47%

Returns comparison

Trailing returns across standard periods

About Kimberly Clark Corp

With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

Read more on KMB

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases

Read more on REGN